Identification of biomarkers for acetaminophen toxicity

Acetaminophen is a popular over-the-counter medication for the treatment of pain and fever. While the medication is safe and effective when taken in normal dosages, when taken in amounts greater than those recommended the drug has been shown to be toxic, most notably to the liver. This study is looking to identify markers in your blood that may signify whether or not liver injury has taken place.

Medication Under Study:

Full study title:
Identification of New Mechanistic Biomarkers of Adverse Responses to Acetaminophen

IRB Study ID:

Who may qualify:

Pediatric patients ages 1-18 years

Who does not qualify:

Patients with a known history of liver disease

If you are interested in this study or have questions about your child's eligibility, please contact:

Rebecca D. Considine Research Institute: 330-543-5012

For urgent patient care matters involving a current study patient, please call: 330-920-5774

Lead Principal Investigator:

Michael Reed, PharmD, FCCP, FCP
Director, Rebecca D. Considine Research Institute
Director, Division of Pharmacology and Toxicology

Bookmark and Share

iGrow iGrow
Sign up for our parent enewsletter
    Contact Us



    find a location
    Find a location Type the first 3-5 letters of a specialty, service or location:
    Or, view: a map, a list of all locations, locations by city or locations near me.
    find a doctor
    Find a doctor Type the first 3-5 letters of the name, location or specialty:
    Or, view a list of all doctors by name, location and specialty.